Therapy of nitric oxide in neonatology

• Artem A. Burov

Abstract

Persistent pulmonary hypertension of the newborn remains unfavorable for disease course and outcome of the disease in the newborn. All selective vasodilators for neonates have the off-label status in our country, the article analyzed the studies of nitric oxide therapy in persistent pulmonary hypertension of the newborn and premature babies, as well as examine the technical and organizational aspects of this technology аt newborn.

Keywords:nitric oxide (NO), persistent pulmonary hypertension of the newborn, bronchopulmonary dysplasia

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)